Reducing Cardiovascular Risk in Type 2 Diabetes: What I Do and Why

Learn strategies to reduce cardiovascular risk in your patients with T2DM. Hear from a leading endocrinologist cardiologist and primary care clinician as they discuss how they would manage a series of patients highlighting the spectrum of cardiovascular risk.

Share

Program Content

Activities

Reducing CV Risk: Slides
Slides to Guide Reducing Cardiovascular Risk in Type 2 Diabetes: What I Do and Why
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2018

Expires: June 28, 2019

Activities

Reducing CV Risk: Video
Management of Type 2 Diabetes in Patients With Cardiovascular Risk
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2018

Expires: July 19, 2019

Faculty

cover img faculity

Zachary T. Bloomgarden, MD, MACE

Clinical Professor
Division of Endocrinology
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Mikhail N. Kosiborod, MD

Professor of Medicine
Kansas City School of Medicine
University of Missouri
Consulting Cardiologist
Division of Cardiovascular Research
Department of Cardiology
Saint Lukes Mid America Heart Institute
Kansas City, Missouri

cover img faculity

Pamela Kushner, MD, FAAFP

Clinical Professor
University of California Irvine Medical Center
Irvine, California
Director
Kushner Wellness
Los Alamitos, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Boehringer Ingelheim Pharmaceuticals and Lilly USA LLC